Your Partners in Innovation, Every Step of the Way
Bridging the gap from research to real-world impact, together.
Bridging Research and Real-World Impact
Transforming Research into Practical Solutions
Third Eye Associates provides three different core services to guide you in translating research into clinical practice.



Top 5 Critical Problems and How We Solve Them
Access to leadership and management resources
The problem: Progress stalls due to gaps in leadership and management expertise.
Traditional approach: Executive searches can take over three months. Turning to consulting firms or selling the business can be slow and expensive.
- Embedded fractional leadership to accelerate progress
- Rapid deployment to execute strategy and achieve milestones
- We leverage our own deep startup experience and networks to support and accelerate your product development
Translating Benchtop Science Into Commercial Success
The problem: Founders and principal Investigators often lack experience in life-science product development.
Traditional approach: Research is not product development, and many technologies stall without appropriate clinical and regulatory endpoints or a clearly defined market opportunity.
- Support founder teams with phase-appropriate product development expertise
- Design and execute studies to accelerate path to market
- Align scientific research with clinical enpoints and regulatory pathways
- Our team has extensive experience in taking a broad range of life-science technologies, including their own, from conception through clinical development and market launch
Navigating Regulatory Pathways
The problem: Needless delays in development due to viewing FDA as an opponent.
Traditional approach: Businesses typically hire a regulatory consultant only after issues arise and underestimate the importance of regulatory strategy in every aspect of the product development life cycle.
- We establish a relationship with FDA to negotiate a new or more expeditious path forward
- Guide early engagement, risk management, and documentation
- Focus on strategic communication and strong regulatory positioning
- Our team has experience in filing hundreds of pivotal regulatory submissions, including IND, CTA, NDA, IDE, CE, 510(k), and PMA
Quantifying the Commercial Opportunity
The problem: There is inadequate clarity on market opportuity to attract investors.
Traditional approach: With limited bandwidth, resources, or experience, it is difficult to establish a realistic product development budget and timeline.
- Provide independent, honest assessments of market opportunity informed by technical, clinical, regulatory, and business experience
- Develop realistic plans to meet technical, clinical, and regulatory milestones with proposed budgets
- Our team provides GAP analyses to both in-house teams and potential investors to quantify commercial opportunity
Funding Challenges
The problem: There is inadequate positioning of the technology to attract the right investors, and leadership has not crafted the best story to obtain competitive non-dilutional funding.
- Leverage our experience in fund-raising success to mitigate development and investment risk, and maximize opportunity attractiveness
- Leverage our experience in winning tens of millions USD in grants to accelerate your non-dilutional funding strategy
- Our Principals have successfully supported and obtained funding from angel, venture, NIH, NSF, DOD, and other national funding bodies, as well as have participated as reviewing experts for various award panels.
How We Support Your Vision
Our Approach



Why Choose Us?
Why Academics and Entrepreneurs Choose Third Eye Associates
- Expertise in research-to-clinical pathways
- Specialized academic and entrepreneurial focus
- Established network within clinical sectors
- Proven track record in achieving market readiness for research projects


